PACB
Pacific Biosciences of California, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.35
+3.85%Margins
Gross margin
36.0%
EBITDA margin
-68.5%
EBIT margin
-102.1%
Net margin
-82.5%
FCF margin
-107.5%
395.6%
Return on equity
-17.5%
Return on assets
-24.2%
Return on invested capital
0.21x
Asset turnover
-$162.7M
Cash from operations
$0.76
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026